Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies

被引:31
作者
Gambacorti-Passerini, C
Gasser, M
Ahmed, S
Assouline, S
Scapozza, L
机构
[1] Univ Geneva, Sch Pharmaceut Sci, Lab Chim Therapeut, CH-1211 Geneva, Switzerland
[2] Univ Milan, Milan, Italy
[3] Natl Canc Inst, I-20133 Milan, Italy
[4] McGill Univ, Dept Oncol, Montreal, PQ, Canada
[5] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, ETH, Zurich, Switzerland
关键词
D O I
10.1038/sj.leu.2403775
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1267 / 1269
页数:4
相关论文
共 7 条
[1]   A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase [J].
Atwell, S ;
Adams, JM ;
Badger, J ;
Buchanan, MD ;
Feil, IK ;
Froning, KJ ;
Gao, X ;
Hendle, J ;
Keegan, K ;
Leon, BC ;
Müller-Dieckmann, HJ ;
Nienaber, VL ;
Noland, BW ;
Post, K ;
Rajashankar, KR ;
Ramos, A ;
Russell, M ;
Burley, SK ;
Buchanan, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) :55827-55832
[2]   Analysis of the structural basis of specificity of inhibition of the Abl kinase by STI571 [J].
Corbin, AS ;
Buchdunger, E ;
Pascal, F ;
Druker, BJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :32214-32219
[3]   Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog [J].
Hubbard, SR .
EMBO JOURNAL, 1997, 16 (18) :5572-5581
[4]  
Nagar B, 2002, CANCER RES, V62, P4236
[5]   A fast flexible docking method using an incremental construction algorithm [J].
Rarey, M ;
Kramer, B ;
Lengauer, T ;
Klebe, G .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 261 (03) :470-489
[6]   Overriding imatinib resistance with a novel ABL kinase inhibitor [J].
Shah, NP ;
Tran, C ;
Lee, FY ;
Chen, P ;
Norris, D ;
Sawyers, CL .
SCIENCE, 2004, 305 (5682) :399-401
[7]   Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation [J].
Yamaguchi, H ;
Hendrickson, WA .
NATURE, 1996, 384 (6608) :484-489